Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.04B |
| 2 |
Verizon
VZ
|
+$459M |
| 3 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$448M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$738M |
| 2 |
iShares MBS ETF
MBB
|
+$390M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$216M |
| 4 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$202M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$186M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.49% |
| 2 | Financials | 13.78% |
| 3 | Healthcare | 13.39% |
| 4 | Industrials | 9.54% |
| 5 | Consumer Discretionary | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VLTA
3126
DELISTED
Volta Inc.
VLTA
| $283K | ﹤0.01% |
795,965
-102,817
| -11% | -$78.1K |
|
|
LONA
3127
LeonaBio Inc
LONA
$66.3M
| $282K | ﹤0.01% |
8,880
| – | – |
|
|
PVBC
3128
DELISTED
Provident Bancorp
PVBC
| $281K | ﹤0.01% |
38,606
+1,040
| +3% | +$10.6K |
|
3129
Instil Bio
TIL
$48.3M
| $280K | ﹤0.01% |
22,241
-1,315
| -6% | -$65K |
|
|
BBIG
3130
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $280K | ﹤0.01% |
30,168
+1,695
| +6% | +$26.1K |
|
3131
Applied Digital
APLD
$7.89B
| $278K | ﹤0.01% |
151,326
+133,605
| +754% | +$263K |
|
3132
Aveanna Healthcare
AVAH
$2.04B
| $277K | ﹤0.01% |
355,759
+22,836
| +7% | +$23.9K |
|
3133
Torrid Holdings
CURV
$254M
| $277K | ﹤0.01% |
93,722
+15,321
| +20% | +$62.5K |
|
3134
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $273K | ﹤0.01% |
3,705
-1,939
| -34% | -$143K |
|
3135
Velocity Financial
VEL
$689M
| $272K | ﹤0.01% |
28,217
| – | – |
|
3136
Viking Therapeutics
VKTX
$3.7B
| $272K | ﹤0.01% |
28,966
| – | – |
|
|
PFSW
3137
DELISTED
PFSweb, Inc.
PFSW
| $271K | ﹤0.01% |
44,144
| – | – |
|
3138
Offerpad Solutions
OPAD
$18.3M
| $270K | ﹤0.01% |
3,909
+492
| +14% | +$56.8K |
|
|
BINI
3139
DELISTED
Bollinger Innovations
BINI
| – | – |
0
| – | – |
|
3140
Lifetime Brands
LCUT
$191M
| $265K | ﹤0.01% |
34,901
+1,197
| +4% | +$9.23K |
|
3141
Praxis Precision Medicines
PRAX
$8.58B
| $263K | ﹤0.01% |
7,358
+1,746
| +31% | +$54.5K |
|
|
SBT
3142
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $262K | ﹤0.01% |
43,054
+1,660
| +4% | +$10.4K |
|
3143
Mastech Digital
MHH
$93.1M
| $261K | ﹤0.01% |
23,684
-17,606
| -43% | -$245K |
|
3144
Playboy Inc
PLBY
$128M
| $258K | ﹤0.01% |
93,927
+4,726
| +5% | +$16.9K |
|
3145
Priority Technology Holdings
PRTH
$535M
| $257K | ﹤0.01% |
48,838
| – | – |
|
|
JNCE
3146
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $251K | ﹤0.01% |
226,160
-16,599
| -7% | -$23.6K |
|
|
ALLK
3147
DELISTED
Allakos
ALLK
| $251K | ﹤0.01% |
29,756
-7,050
| -19% | -$49K |
|
3148
EyePoint Inc
EYPT
$1.03B
| $249K | ﹤0.01% |
71,282
+2,460
| +4% | +$10.9K |
|
3149
TherapeuticsMD
TXMD
$23.5M
| $249K | ﹤0.01% |
+44,457
| New | +$262K |
|
3150
Crawford & Co Class A
CRD.A
$532M
| $245K | ﹤0.01% |
44,118
| – | – |
|
Similar funds
Charles Schwab's Q4 2022 Portfolio in Review
As of Q4 2022, Charles Schwab held 3,632 positions worth $310B, up 11% from $279B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Charles Schwab's Q4 2022 filing shows 124 new, 2,654 increased, 459 reduced and 86 closed positions. Its largest new stake was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M. The largest sale was Vanguard Intermediate-Term Treasury ETF, an estimated $738M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2022 buy was iShares 0-5 Year TIPS Bond ETF: 4,612,793 shares worth $447M.
- Charles Schwab added most to iShares 7-10 Year Treasury Bond ETF in Q4 2022, an estimated $1.04B increase.
- Charles Schwab's biggest Q4 2022 reduction was Vanguard Intermediate-Term Treasury ETF, cutting an estimated $738M.
- Charles Schwab fully exited Duke Realty Corp. in Q4 2022, selling an estimated $175M.
- Charles Schwab's ten largest holdings make up 16% of its $310B portfolio in Q4 2022.
- Charles Schwab opened 124 new positions and closed 86 in Q4 2022.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $310B.
Based on Charles Schwab's 13F filing for Q4 2022, filed 13 Feb 2023.